Based on Genetic Engineering & Biotechnology News’ list of best-selling drugs between 2000 and 2011, Pfizer’s LIPITOR topped the list with $121.4 billion in sales. Sanofi/Bristol-Myers Squibb’s PLAVIX was number two with $74.6 billion in sales.
Sanofi’s LOVENOX also appeared in the top 10.